Evolve Business Intelligence released a new market research report on Global SNP Genotyping and Analysis Market by Technology (SNP Microarray, Taqman Allele Discrimination, SNP Pyrosequencing Technologies, ABISNPlex, Sequenom Mass Array MALDI-TOF, Others). Application (Pharmaceuticals and Pharmacogenomics, Diagnostic Research, Agricultural Biotechnology, Breeding and Livestock Husbandry) and by Geography – COVID-19 Impact Analysis, Post-COVID Analysis, Opportunities, Trends and Forecast from 2022 to 2032
The global SNP genotyping and analysis market size is forecast to grow at a CAGR of approximately 23% from 2022 to 2032. The SNP genotyping and analysis market is anticipated to grow during the forecast period. The main factor driving the market growth is the increasing adoption of SNP genotyping techniques in personalized medicine.
Request a free sample report or PDF copy: https://report.evolvebi.com/index.php/sample/request?referer=parity&reportCode=015635
The SNP Genotyping and Analysis market report provides detailed information about the company and its performance to date. This will give you a clear picture of how strong an industry is, what kind of wealth comes with it, and which areas are growing over time. Every single element in a market report is updated regularly to help us read the market better. The report also includes general risks associated with marketing in such a delicate industry as it offers advice for future planning of a related business expansion.
The key players profiled in the report are:
• LGC Limited
• Fluidigma Corporation
• Illumina, Inc.
• Life Technologies Corporation
• PREMIER Biosoft
• Thermo Fisher Scientific,
• Sequenom, Inc.
Today’s business environment is competitive and challenging, which means companies need to keep up with new technologies and seek market opportunities. Our latest research into the global SNP genotyping and analysis industry sheds light on the current state of the…